Related Experiment Video
Updated: Jan 14, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Genetic Familial Interstitial Lung Disease
Rafael J Fernandez1, Jonathan A Kropski2
1Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, 1161 21st Avenue S, T1218 MCN, Nashville, TN 37232, USA. Electronic address: https://twitter.com/rjfernandeziii.
Genetic factors significantly impact interstitial lung diseases (ILDs), influencing treatment and prevention strategies. Early detection through genetic screening in families can improve outcomes for these progressive lung function disorders.
Area of Science:
- Pulmonology
- Genetics
- Pharmacotherapy
Background:
- Interstitial lung diseases (ILDs) are a diverse group of conditions causing progressive lung function decline.
- A portion of ILD cases are attributable to specific single-gene mutations.
- Genetic factors are increasingly recognized as crucial in understanding ILD pathogenesis.
Purpose of the Study:
- To highlight the role of genetic etiologies in ILD.
- To emphasize the impact of genetic findings on pharmacotherapy decisions.
- To discuss the implications for familial screening and disease prevention.
Main Methods:
- Literature review of genetic causes of ILD.
- Analysis of current evidence on pharmacotherapy influenced by genetics.
- Synthesis of recommendations for familial screening and prevention strategies.
Main Results:
- Single-gene causes are identified in a subset of ILD patients.
- Genetic information should guide treatment choices, especially immunosuppression.
- Screening relatives of familial ILD patients is recommended for early detection.
Conclusions:
- Genetic testing is valuable for ILD patients and their families.
- Personalized pharmacotherapy based on genetic profiles is emerging.
- Future research in ILD prevention holds significant promise.
More Related Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...